Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotechnology Angel Investors in United States in December 2024

Last updated: Dec 2024 A list of 50 angel investors that invest in Biotechnology startups based in United states. We rank investors based on the number of investments they made in Biotechnology companies from United states. We update this investor list every month.

Top 50 Biotechnology Angel Investors in United States in December 2024

Investor	Biotechnology United States investments
Milad Alucozai	16
Jaffray Woodriff	10
Jeff Dean	9
Jude Gomila	9
Kingsley Advani	9
bumpkins profile	8
Paul Buchheit	7
Jeff Hammerbacher	7
Alice Zhang	7
Zach Weinberg	6
Sahin Boydas	6
Wei Guo	6
Bill Gates	6
Farzad (Zod) Nazem	5
Mark Cuban	5
Erik Peterson	5
Jim Mellon	5
Anne Wojcicki	5
Chris Gibson	5
David R. Walt	5
Brian Armstrong	5
Elad Gil	5
Kevin Moore	5
Daniel Curran	5
Evan Cheng	5
Nat Turner	4
Eric Kwan	4
Bradley Horowitz	4
Jack Abraham	4
Peter Thiel	4
David Beyer	4
Daren Cotter	4
Sam Altman	4
Balaji Srinivasan	4
Max Levchin	4
Ling Wong	4
Bill Gates	4
John D'Orazio	4
Cory Levy	4
Brenton Saunders	4
Timothy A. Springer	4
Todd Corenson	4
Esther Dyson	4
Brad Flora	4
Darian Shirazi	4
Franklin Berger	3
Jennifer Ehlen	3
Tim Kendall	3
Adrian Aoun	3
Erik Moore	3

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.

Angel Investor located in Charlottesville, VA

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Angel
United States

Portfolio highlights

Yogi — Yogi's analytics platform lets you easily sift through customer Reviews & Ratings data. Get actionable insights from your product Reviews, Ratings, and Sentiment Analysis to improve your brand reputation and product experiences.
Caju AI — Caju AI revolutionizes customer engagement with Generative AI, boosting your workforce's productivity and providing invaluable business insights. Elevate your customer experience with the power of AI.
Starchive — AI enriched Digital Asset Management designed by creators for creators, to maximize the control and ownership of their content, community, and commerce in the Visual Media Economy.

Jeff Dean joined Google in 1999 and is currently a Google Senior Fellow in Google's Research Group, where he leads the Google Brain team, Google's deep learning research team in Mountain View, working on systems for speech recognition, computer vision, language understanding, and various predictive tasks. He has co-designed /implemented five generations of Google's crawling, indexing, and query serving systems, and co-designed / implemented major pieces of Google's initial advertising and AdSense for Content systems. He is also a codesigner and coimplementor of Google's distributed computing infrastructure, including the MapReduce, BigTable and Spanner systems, protocol buffers, LevelDB, and TensorFlow, a popular open-source system for machine learning.Jeff received a Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the Mark Weiser Award and the ACM-Infosys Foundation Award in the Computing Sciences.

Investment focus

Artificial Intelligence, Biotechnology, Information Technology
Seed, Series A, Pre-Seed
United States, Japan, Australia

Portfolio highlights

TollBit — The platform for AI content licensing at scale. TollBit helps you monitor AI traffic, manage licensing deals & monetize your content in the AI era.
Roboflow — With just a few dozen example images, you can train a working, state-of-the-art computer vision model in less than 24 hours
Marimo — Marimo is an open-source reactive platform for developers working on Python.

Jude Gomila is currently CEO and Founder of the startup Golden.

Investment focus

Software, Biotechnology, Information Technology
Seed, Pre-Seed, Angel
United States, United Kingdom, Canada

Portfolio highlights

Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!

Kingsley Advani is a British investor. He started investing in 2013, funding 50 companies, 4 funds and donating to non-profits including: SENS Foundation, Methuselah Foundation, Stanford University, National University of Singapore. He is particularly interested in regenerative medicine for age-related disease. Investments: Oisin, Turn Bio,Oncosenx, Monzo, Robinhood, Abra, Coinbase, Momentus, Demonpores, 64-x, Nectome. Investment areas: biotechnology, neurotechnology, longevity, space, fintech.

Investment focus

FinTech, Financial Services, Biotechnology
Seed, Pre-Seed, Series A
United States, Singapore, United Kingdom

Portfolio highlights

Checkstep — AI Content Moderation Services: learn how AI can help you scale your content moderation and keep your users and moderators safe.
Allocations — 10,000+ investors and fund managers build, onboard and close funds on Allocations - the fastest and most advanced fund platform in the world
Ashvattha Therapeutics — Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
Character.ai — Chat with millions of AI Characters anytime, anywhere. Super-intelligent chat bots that hear you, understand you, and remember you. Free to use with no ads.
Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Jeff Hammerbacher - Partner & Co-Founder @ Techammer

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Series A, Angel
United States

Portfolio highlights

Modal Labs — Modal develops machine learning software to help run code in the cloud. The software enables users to run or deploy machine learning models, massively parallel compute jobs, task queues, web apps, and more. It also writes the code to launch hundreds of custom containers and runs scripts in the cloud faster than on the local machine.
Potato AI — A literature-based research assistant to plan, collaborate on, and run reproducible protocols.
All Hands AI — All Hands AI operates as an open source agent for developers.

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, United Kingdom

Portfolio highlights

Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Investment focus

Health Care, Software, SaaS
Seed, Series A, Pre-Seed
United States, Israel, United Kingdom

Portfolio highlights

Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.

Sahin Boydas is Head of Turkiye, Distributed Teams, Bootcamp, and App Ecosystem at Gusto. He was the CEO & Founder of RemoteTeam. He attended Koç University.

Investment focus

Software, Financial Services, FinTech
Seed, Series A, Series B
United States, Mexico, Spain

Portfolio highlights

Brellium — Clinics use Brellium to automate chart review with AI. Reduce your QA costs by 98%, audit all clinical notes in real time, and decrease clawback risk.
Superunit — Superunit is a Software Development firm offering accounting and inventory solutions to their clients.
Modus — Unlock revenue per employee. Modus brings finance, HR, and hiring managers to detect, inspect, and correct their workforce plans - in one unified workflow. Our AI will always ensure capacity meets revenue.

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Playbook — Playbook gives creators the opportunity to build and grow a subscription business. Fans get an all-access pass to a curated health and wellness content.
Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Investment focus

Energy, Biotechnology, Manufacturing
Series C, Series A, Series B
United States, Canada, Israel

Portfolio highlights

Heineken — Welcome to the global website for Heineken International. Find information about our company, history, brands, strategy and careers here.
Inflection AI — Inflection AI is a machine learning startup that engages in redefining human-computer interaction.
Lucy Therapeutics — Lucy Therapeutics, a Boston-based biotech with a unifying mitochondrial platform, is developing small molecule treatments for neurological diseases.

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.

Investment focus

Health Care, Analytics, Machine Learning
Seed, Series A, Series B
United States, Canada

Portfolio highlights

Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
Ceevra — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
TigerGraph — TigerGraph is a platform for advanced analytics and machine learning on connected data. Based on the industry’s first and only distributed native graph database, TigerGraph’s proven technology supports advanced analytics and machine learning applications such as fraud detection, anti-money laundering (AML), entity resolution, customer 360,recommendations, knowledge graph, cybersecurity, supply chain, IoT, and network analysis. The company is headquartered in Redwood City, California, USA. Start free with tigergraph.com/cloud.

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Investment focus

Software, Artificial Intelligence, Blockchain
Seed, Series A, Angel
United States, United Kingdom, Singapore

Portfolio highlights

DIRT Research Technologies — DIRT is an AI-powered content measurement engine enabling AI models to recognize, evaluate, and generate content that grabs attention and predicts engagement. Linking human attention to images and videos, we teach models to understand what people are most interested in engaging with, watching, and playing. At DIRT, what you make matters. We makesure it connects.
TransCrypts — We all have that file box where we throw all our important documents. Our goal at TransCrypts is to make that box digital and have all the documents secured through the blockchain. We currently offer industry leading privacy and security standards on our file storage and sharing platform and have solutions for individuals all the way to enterprises.
Matter Intelligence — Matter Intelligence is creating the most detailed map of the world using first-of-a-kind sensors to understand our planet like never before

Erik Peterson is the Founder at DormTrader.

Investment focus

Software, Biotechnology, SaaS
Seed, Equity Crowdfunding, Series A
United States, Canada, Algeria

Portfolio highlights

Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Investment focus

Biotechnology, Food and Beverage, Health Care
Series A, Seed, Funding Round
United States, United Kingdom, Germany

Portfolio highlights

Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.

Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Series B
United States, United Kingdom, Canada

Portfolio highlights

Midi Health — Expert care for women 40+. Made for midlife. Delivered by experienced clinicians. Covered by insurance. Book a visit today.
Solace — Connect with expert patient advocates who can help you navigate the healthcare system and solve any medical problem, no matter what you need.
Brightside Health — Get anxiety and depression treatment online from licensed psychiatric providers and therapists. No need to wait, start a free consultation online today.

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Seed
United States, France, Switzerland

Portfolio highlights

Amenities Health — Discover your dedicated Digital Front Door platform that enhances the patient experience and foster brand loyalty.
Cradle — Design better proteins
Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

Investment focus

Biotechnology, Genetics, Life Science
Seed, Series A, Series B
United States

Portfolio highlights

Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Brian Armstrong is the CEO and Co-Founder of Coinbase. He previously worked at Airbnb.com as a Technical Product Manager. Brian Armstrong attended Rice University.

Investment focus

Payments, Financial Services, Banking
Seed, Series A, Series B
United States, Brazil

Portfolio highlights

Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Series B
United States, United Kingdom, Israel

Portfolio highlights

Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
Decagon — Trusted by world-class companies, Decagon is the most advanced AI platform for customer support.
Braintrust Data — The end-to-end platform for building world-class AI products

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Investment focus

Software, Health Care, E-Commerce
Seed, Pre-Seed, Angel
United States, India, Canada

Portfolio highlights

Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Augmend — Create documentation and an AI assistant from any video.

Daniel Curran is the Founder and CEO at CustEx.com.

Investment focus

E-Commerce, Software, Internet
Seed, Series A, Series B
United States, Canada, Brazil

Portfolio highlights

CARD.com — Fully featured bank account with optional overdraft protection and round up savings account. Get your paycheck up to 2 days earlier.
RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
GC Plus — Find Your Next Home Service Expert With Ease

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Pre-Seed, Funding Round
United States, United Kingdom, Australia

Portfolio highlights

PARSIQ — Explore the future of blockchain with PARSIQ - Your gateway to advanced blockchain monitoring, smart triggers, and real-time intelligence. Empower your crypto journey with cutting-edge technology and unparalleled insights. Join us in revolutionizing the way you interact with the blockchain ecosystem
PIN AI — PIN AI democratizes personal on-device intelligence for everyone; transform your digital footprints into your Personal Executive Assistant.
Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.

Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerousinternet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.

Investment focus

Health Care, Software, Medical
Seed, Series A, Series B
United States, China, Colombia

Portfolio highlights

CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
Collectors — Helping collectors to pursue their passion.
Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes

Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures

Investment focus

Software, FinTech, E-Commerce
Seed, Pre-Seed, Funding Round
United States, India, Canada

Portfolio highlights

Treinta — Treinta is a digital ledger app for Latin American microbusinesses. Through Treinta, users can easily record transactions by assigning products from their inventory and see how their business metrics evolve in real time. The app helps owners save up to 30 minutes a day in bookkeeping related tasks and improve efficiency by over 30%. Out of the 50million microbusinesses in LATAM, today 90% still track their sales and expenses by using pen and paper.
Ferveret — Ferveret develops liquid cooling technology for data centers and other infrastructure. Our company is backed by Y Combinator and MIT Media Lab's E14.
Kriya AI is now Kalendar AI — Kalendar AI books new revenue on autopilot

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
United States, United Kingdom, Germany

Portfolio highlights

Mill — Meet the cleanest, easiest way to prevent food waste at home. Mill recycles your peels, bones, stalks, and forgotten leftovers.
Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
Overture Life — We are making In Vitro Fertilization (IVF) more accessible than ever before while improving success rates. An embryology lab in a box.

Jack Abraham is the Founder and Managing Partner of Atomic. He previously worked at TalkIQ as a Co-founder and Investor. Jack Abraham attended The Wharton School.

Investment focus

Health Care, Financial Services, Biotechnology
Seed, Series A, Series B
United States

Portfolio highlights

Gameto — Gameto is a new breed of biotechnology company in female reproductive longevity
Dispatch — OneAdvisory helps independent financial advisors to build ideal firms through strategic investments and advanced technology. The company was founded in 2022 and is headquartered in Miami, Florida.
Software Applications Incorporated — Rethinking the personal computing experience

Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.

Investment focus

Software, FinTech, Financial Services
Series A, Seed, Series B
United States, Germany, Canada

Portfolio highlights

Etched.ai — Transformers etched into silicon. By burning the transformer architecture into our chips, we're creating the world's most powerful servers for transformer inference.
Enhanced Games — Welcome to the Enhanced Games, the ultimate demonstration of what the human body is capable of. The world's best athletes, enhanced.
Alias Technologies — Here at Alias Technologies our goal is to help organizations tackle complex IT goals and initiatives in an ever-changing landscape. Leveraging our Partner relationships and extensive experience we are able to help position our customers for the future.

David is a Partner of Amplify Partners and co-founder of Chartio.com.Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He wassubsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies. David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Skycatch, Caribou Biosciences, Rigetti Computing, Casetext, Ginkgo Bioworks, Function of Beauty, Cruise Automation, and Bugcrowd. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.He attended Brown University.

Investment focus

Software, Artificial Intelligence, Enterprise Software
Seed, Angel, Series A
United States

Portfolio highlights

Airtable — Airtable is a cloud-based software company that offers an easy-to-use online platform for creating and sharing relational databases.It brings the database out of the realm of power users and into the mainstream, creating a new type of flexible but sophisticated productivity tool that anyone can use. Airtable gives end-users the ability to createand share their own workflows for everything from managing an editorial calendar to planning a major event. The platform helps create flexible checklists, organize collections or ideas, and manage customers or contacts as well as offers a variety of templates ranging from home improvement to store inventory, enabling users to build custom applications without any prior coding experience.The company was founded by Andrew Ofstad, Emmett Nicholas, and Howie Liu in 2013 and is headquartered in San Francisco, California.
Astranis — Four billion people still have no internet access. Astranis is here to change that. We're making small satellites for geostationary orbit, recently signed a contract to triple the satellite internet capacity of Alaska, and raised our Series A from Andreessen Horowitz.
Ginkgo Bioworks — Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria toprotect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

Daren was the Founder and CEO of InboxDollars, an online marketing company that connects consumers and advertisers in a way that benefits both. He founded the company as a Freshman in college in 2000 and bootstrapped the company to more than $25 million in annual revenues. InboxDollars was acquired by Prodege in 2019. Daren is active in the MNstart-up community as an investor, advisor and mentor.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Funding Round
United States

Portfolio highlights

AnyCreek — AnyCreek is a platform that facilitates the booking of outdoor adventures such as fishing or hunting trips. It aims to connect adventure-seekers with guides and outfitters, providing a space for them to discover and book the best outdoor experiences. The platform is designed to be guide-friendly, empowering guides and outfitters to reach a wideraudience.
Coldcart — Coldcart is a technology platform which orchestrates, optimizes and scales frozen and refrigerated parcel logistics for leading D2C and B2B companies - unlocking unprecedented new efficiencies in perishable parcel logistics.
Pear Commerce — Pear is the retail ecommerce platform that connects omnichannel CPG brands to retailers, combining shoppable media, where-to-buy, and closed-loop data to help strategically capture greater share of wallet.

Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator from 2016 through 2019. Sam Altman attended Stanford University.

Investment focus

Software, Internet, Artificial Intelligence
Seed, Series A, Series B
United States, Canada, Ghana

Portfolio highlights

GALY — Saving Our Planet by Transitioning the World to Cellular Agriculture
Beacon AI — Beacon AI is building the future of flight safety for commercial and private fleets.
ValueBase — This page discusses the history of ValueBase, what brought us together and why we decided that accurate appraisal was important. It also explains why we focus on mass appraisal and statistical techniques like regression.

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.

Investment focus

Blockchain, Cryptocurrency, Software
Seed, Pre-Seed, Series A
United States, India, Singapore

Portfolio highlights

ZAR — Enjoy borderless banking with a USD Visa card powered by stablecoins. Available in 180+ countries. Sign up for your account today!
The Arena — Arena. social is a cutting-edge SocialFi platform that is revolutionizing how content producers interact, network, and make money from their work.
OpenGradient — OpenGradient is a leading decentralized AI platform for open-source model hosting, secure inference, agentic reasoning, and application deployment. By developing tooling and a feature-rich platform that makes developing AI workflows both secure and seamless, OpenGradient empowers developers with the ability to build in its ecosystem of intelligentand optimized AI-empowered applications. With native model hosting, permissionless composability, and secure inference execution, OpenGradient also aims to accelerate open-source AI by democratizing model ownership, improving verifiability guarantees, and promoting censorship-resistant model access.Our heterogeneous AI compute architecture (HACA) and our proprietary library NeuroML scale secure AI workflows with features like inference, agentic reasoning, statistical analysis, and more. OpenGradient also accelerates open-source innovation with a web portal and SDK for Web2 developers to leverage our AI stack without navigating blockchain complexities, while enjoying the security and composability benefits of decentralized infrastructure.

Max Levchin is the Founder and CEO of Affirm. He previously worked at the Consumer Financial Protection Bureau as an Advisory Board Member. Max Levchin attended the University of Illinois Urbana-Champaign.

Investment focus

FinTech, Financial Services, Internet
Series A, Seed, Series B
United States, United Kingdom, India

Portfolio highlights

Bland AI — Transform your enterprise communication with Bland AI. Automate inbound and outbound phone calls using AI that sounds human. Perfect for sales, customer support, and operations with customizable voices and seamless integrations.
CoPilot — CoPilot is pioneering Assisted Commerce for big-ticket purchases – starting with cars. You are the one spending the money - shouldn't you have an expert on your side? We founded CoPilot to make that a reality. For the average car buyer, who is not a car expert or enthusiast, car shopping can be a time consuming, frustrating process that leavespeople feeling alone and disadvantaged. CoPilot is changing this dynamic. Like a trusted friend who is knowledgeable about cars, knows where to look and what to buy, CoPilot provides car shoppers with an expert partner who empowers them to discover the perfect car at the best possible price with ease and confidence.
Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.

Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
United States, Colombia

Portfolio highlights

Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Investment focus

Energy, Biotechnology, Manufacturing
Series A, Series C, Series B
United States, Brazil, Canada

Portfolio highlights

Mainspring Energy — Mainspring Energy is engineering advanced technology to revolutionize the way electricity is generated and delivered
Heineken — Welcome to the global website for Heineken International. Find information about our company, history, brands, strategy and careers here.
Inflection AI — Inflection AI is a machine learning startup that engages in redefining human-computer interaction.

John is the Founder and CEO of Capture Collective.

Investment focus

Biotechnology, Medical, Health Care
Seed, Funding Round, Equity Crowdfunding
United States

Portfolio highlights

RenovoDerm — A medical device company building a line of wound care products that provide a structure for tissue growth and promote faster healing of wounds—while reducing scar tissue. Funding prior to formation: $1.6 million.
Vascular Genesis — A medical device company laying the foundation for vascular conduit replacement with its line of cell-free, synthetic scaffold products -- with self-healing capabilities that lower the risk of rejection, infection, and stenosis. Funding prior to formation: $2.5 million.
Atreon Orthopedics — A medical device company building a line of orthopedic products that provide a structure for tissue growth and healing of sports medicine injuries including tendon ruptures/tears.

Cory Levy is the Founder Advisor of Humaning.

Investment focus

Software, Artificial Intelligence, Information Technology
Pre-Seed, Seed, Grant
United States, India, Canada

Portfolio highlights

Omen AI — Harness the power of Ai and proprietary sensing to prevent equipment failures.
Butler — Streamline your workflow with AI-powered summaries, contextual chat, a native meeting bot and more, all in one place.
Slingshot AI — Slingshot is an AI research company driven by our mission to exponentially increase global access to mental healthcare.We’re developing technology to help humans feel and perform better, be more connected, and adapt to the future in a time where the demand for mental health support far exceeds providers by 10,000:1, and the large-scale changesahead are unprecedented.By leveraging AI to delve deep into human psychology, we expect to learn something about human nature that no humans have before, in order to help people change their minds.Based in NYC and London, our cross-disciplinary team of researchers, engineers, and broader mental health experts is dedicated to building tools that empower individuals to take on any challenge that arises.

Brenton Saunders is the current Chief Executive Officer of Bausch & Lomb. He previously worked at The Allergan Foundation as a Chairman. Brenton Saunders attended Temple University’s Fox School of Business.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Series B
United States

Portfolio highlights

Wondermind — Welcome to Wondermind, your home for approachable, expert-backed mental health content you can actually use.
Nucleus — Nucleus provides genetic analysis of greater breadth, depth, and beauty. Users can upload their genetic information obtained through an established company. The proprietary algorithms will calculate polygenic risk scores and measure disease risk based on analysis of genetic variants and display them in a user-friendly platform.
Lipidio Pharmaceuticals — A Unique Approach to Treating Obesity Precision Targeting of the Skin Exploiting the skin as an endocrine organ Historically regarded as a protective barrier organ, the skin is now recognized as an active endocrine organ capable of synthesizing, and secreting diverse hormones and signaling

Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™.

Investment focus

Biotechnology, Medical, Health Care
Series B, Series A, Seed
United States, Canada

Portfolio highlights

Prenuvo — Changing the medical paradigm from sick care to proactive healthcare
Seismic Therapeutic — Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements ofbiologics drug discovery – structural biology, protein engineering, and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases.
Tectonic Therapeutic — Tectonic and AVROBIO have completed their anticipated merger.Please follow this link to our press release for additional information.

Todd Corenson - Founder @ Enlon

Investment focus

Biotechnology, FinTech, SaaS
Seed, Pre-Seed, Convertible Note
United States

Portfolio highlights

Solugen — Solugen's mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale.Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with thecompetition.
HelixNano — Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
iMicrobes — We are a synthetic biology company on the mission to work with the world's largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.

Esther Dyson - Founder @ Way to Wellville

Investment focus

Health Care, Software, Medical
Seed, Series A, Funding Round
United States, Canada, Russian Federation

Portfolio highlights

Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.
Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.

Brad Flora is a Visiting Partner at Y Combinator. He is a former Co-Founder and CEO of Perfect Audience. Mr. Flora received a BA from Princeton University in English and an MS in Journalism from Northwestern.

Investment focus

Software, SaaS, FinTech
Seed, Pre-Seed, Series A
United States, United Kingdom, Mexico

Portfolio highlights

SWAP — Swap empowers companies to transform their financial operation with an innovative approach, technology, and business model. SWAP’s APIs offer clients end-to-end, white-label, financial solutions. Connected to them, its clients are able to develop complete financial ecosystems including pre-paid cards, digital wallets, financial services and furthermonetize their platform while expanding their core experience. It removes barriers and generates new business lines for companies, effectively creating internal fintech.
Wallet.ng — Wallet.ng is a fintech startup that allows people and companies to send, receive, and make payments, using their phone numbers.The company's infrastructure also provides plugins and libraries for merchants to accept payments online with just a URL. Wallet.ng users can pay directly into bank accounts and Pay Utility Bills in Nigeria.Wallet.ng is a mobile payment solution, its core infrastructure is built using technologies which is adaptable for multiple countries across Africa.It was established in Lagos, Lagos by John Oluranti Oke and Joseph Benson-Aruna in 2018..
Ellipsis — Automated code reviews and bug fixes. Software engineers are more productive with Ellipsis, a developer tool that catches bugs, answers questions, and generates working, tested code.

Darian Shirazi is the Managaing Partner of Gradient.

Investment focus

Software, Information Technology, SaaS
Seed, Series A, Series B
United States, Germany, Canada

Portfolio highlights

Valdera — Valdera is the sourcing and procurement platform that makes it easy to buy or sell chemicals, ingredients, and raw materials. We partner with segment leaders, ranging from the world's largest CPG manufacturers to household names in the beauty industry.
Leya — By streamlining and simplifying legal workflows, we empower elite law firms and legal professionals to work more efficiently and effectively. Enabling them to focus on higher-value tasks and deliver exceptional results for their clients.
rift — The sales platform built to help your focus.

Franklin Berger has served as a member of our board of directors since September 2010. Franklin Berger is a consultant to biotechnology industry participants, including major biopharmaceutical firms, mid-capitalization biotechnology companies, specialist asset managers and venture capital companies, providing business development, strategicadvisory, financing, partnering, and royalty acquisition advice. Franklin Berger is also a biotechnology industry analyst with over 25 years of experience in capital markets and financial analysis. Franklin Berger worked at Sectoral Asset Management as a founder of the small-cap focused NEMO Fund from 2007 through June 2008.From May 1998 to March 2003, he served at J.P. Morgan Securities, most recently as Managing Director, Equity Research and Senior Biotechnology Analyst. In this position, he initiated coverage of 26 biotechnology companies and was responsible for technical, scientific and clinical due diligence as well as company selection.Franklin began his career as a sell-side analyst at Josephthal & Co. in 1991, subsequently moving to Salomon Smith Barney in 1997 serving as Director, Equity Research and Senior Biotechnology Analyst. Franklin currently serves on the board of directors of three biotechnology companies: Five Prime Therapeutics, Inc., Immune Design Corp. and Bellus Health, Inc. Previous public company board service included 11 years with Seattle Genetics, Inc., 7 years with VaxGen, Inc. and Aurinia Pharmaceuticals Inc. (previously Isotechnika Pharma Inc.), based in Canada. He also serves or has served on biotech company boards of directors including iTherX Pharma, Inc., Caprion Proteomics Inc. and ViroChem Pharma, Inc. (purchased by Vertex Pharmaceuticals, Inc. for $400 million in 2009). Franklin has led multiple M&A analyses resulting in greater than $1 billion in transaction value.. Franklin received a B.A. in International Relations and an M.A. in International Economics both from Johns Hopkins University and an M.B.A. from the Harvard Business School.

Investment focus

Health Care, Therapeutics, Biotechnology
Seed, Series A, Series B
United States

Portfolio highlights

MindRhythm — MindRhythm is a medical device company focused on applying novel biometrics to stroke and concussion patients to improve diagnosis, triage and management. Their proprietary monitoring devices and communication platform provide novel and real-time visibility to life-threatening situations prehospital and in the operating room, allowing clinicians tointervene earlier and with better precision to prevent brain damage.
Auron Therapeutics — A differentiated approach to cure cancer.
Amphivena Therapeutics — Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Its Amphivena ReSTORE platform provides dual-action biologics that relieve immune suppression and activate T cell effector function in cancer patients. The platform design integrates elements of avidity, target selectivity, andenhanced safety within a single molecule. It is also can be engineered with additional solid tumor targeting modalities to add functionality such as directed tumor cell killing.It was founded in 2012 and is headquartered in South San Francisco, California.

Jennifer Ehlen - Founder & CEO @ Brazen Global

Investment focus

Genetics, Health Care, Biotechnology
Pre-Seed, Series A
United States

Portfolio highlights

AEENA Dx — A brilliant shift in disease detection is coming soon. Learn more A brilliant shift in disease detection is coming soon. Learn more

Tim Kendall is the Co-Founder of Moment.He attend to the Stanford University Graduate School of Business in 2004.

Investment focus

Health Care, Artificial Intelligence, E-Commerce
Seed, Series A, Angel
United States

Portfolio highlights

Pendulum — Improve glucose control, metabolic health, gut function, and support a healthy weight. The only brand with live Akkermansia. Pendulum Metabolic Daily | Optimizes metabolism Pendulum Akkermansia | For gut health Pendulum Glucose Control | For A1C management Pendulum Butyricum | For occasional gut discomfort
Alto Neuroscience — Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develophighly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.
Checkmate — Never miss a deal.

Adrian Aoun is the founder and CEO of Forward, an AI-based healthcare system combining world-class private doctors with new technology to enable proactive, data-driven primary care. Most recently, he was the head of Special Projects for the CEO of Google/Alphabet, where he founded one of the Alphabet companies Sidewalk Labs. Adrian arrivedat Google upon the acquisition of his AI startup Wavii, and spent his first year at Google helping to create and build their AI division. Additionally, Adrian is an active angel investor and advisor to a number of technology startups and funds.

Investment focus

Software, Health Care, Information Technology
Seed, Series A, Series B
United States, India, Germany

Portfolio highlights

Fuse — Fuse is securing clean, reliable, global energy abundance, along with US competitiveness, through nuclear fusion & nuclear effects testing.
Range — Experience all-in-one wealth management from Range. Access wealth management services from our team of Certified Financial Planners and unified financial management through one thoughtfully designed platform. Learn more about becoming a member.
ShareWell — Struggling with mental health? ShareWell provides online peer support, a proven mental health alternative for therapy. Get group support when you need it.

Erik Moore is the Founder and Managing Director of Base Ventures, an early-stage tech venture fund. He was one of the first investors in Zappos (sold for 1.2B to Amazon) and an early investor in Plangrid, sold to Autodesk for $875mm. Prior to Base Ventures, Erik spent 15 years in investment banking at Merrill Lynch. He recently joined the boardof the Common Ground Foundation, founded by Grammy, Oscar and Emmy award winning artist, Common, and he currently serves as a board member for P.A.C.E, a private philanthropic group. He was recognized as #10 on a list of the top 25 most influential blacks in tech by Business Insider (John Thompson, Chairman of Microsoft was ranked #1). He mentors and advises several known professional athletes. Erik earned his B.A. from Dartmouth College, an MA in French from the University of Pennsylvania, and his MBA from The Wharton School of Business.

Investment focus

Mobile, Software, E-Commerce
Seed, Series A, Funding Round
United States, Latvia

Portfolio highlights

Swapbox — Swapbox is an easy and convenient delivery system that enables people to send and receive packages using a Swapbox kiosk. The kiosks, which are completely automated, are situated in convenient locations including grocery stores, petrol stations and coffee shops, meaning that customers do not need to rush to the post office by 3pm to send theirpackages. Customers simply place their item/s in the Swapbox kiosk and input their details using the touchscreen. The recipient then collects the package from a local Swapbox using the code they received through text or email. Swapbox sets itself apart by focusing on consumer satisfaction, experience and convenience.Swapbox is currently available in San Francisco and Santa Clara.
Pigeonly — Pigeonly offers reliable inmate communication services, including phone calls, photos, and mail. Stay connected to your loved ones in prison easily and affordably.
Share Practice — Share Practice helps doctors identify and understand the most effective clinical treatments based on the success of other doctors.

Investors by industry

Artificial intelligence